LONGITUDINAL ANALYSIS OF ORGAN STIFFNESS AND CARDIAC FUNCTION IN MYELOFIBROSIS PATIENTS TREATED WITH RUXOLITINIB

EHA Library, Isidora Arsenovic, 4162148

PREGNANCY OUTCOMES AND COMPLICATIONS IN PATIENTS WITH PH-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Kristine Poghosyan, 4162149

ROPEGINTERFERON ALFA-2B DEMONSTRATES SUPERIOR HEMATOLOGIC RESPONSE IN HYDROXYUREA-RESISTANT OR -INTOLERANT POLYCYTHEMIA VERA: PROPENSITY-MATCHED REAL-WORLD ANALYSIS

EHA Library, Junshik Hong, 4162150

SINGLE-CENTER RETROSPECTIVE COHORT STUDY OF JAK2-NEGATIVE ERYTHROCYTOSIS: DEMOGRAPHICS, OUTCOMES, AND TREATMENT STRATEGIES

EHA Library, AHMAD ALABDULKARIM, 4162151

ANALYSIS OF CLINICAL CHARACTERISTICS AND PROGNOSIS IN ESSENTIAL THROMBOCYTHEMIA USING NEXT-GENERATION SEQUENCING

EHA Library, Yueyue Zheng, 4162152

CYTOPENIA IS ASSOCIATED WITH REAL-WORLD DISEASE PROGRESSION AND DIMINISHED SURVIVAL IN PATIENTS WITH MYELOFIBROSIS: ANALYSIS OF A US NATIONAL ADMINISTRATIVE CLAIMS DATABASE

EHA Library, Lindsay Rein, 4162153

THROMBOSIS RISK IN LOW-RISK POLYCYTHEMIA VERA PATIENTS: INSIGHTS FROM A LARGE MEDICAL RECORDS' COHORT

EHA Library, Inbar Cohen, 4162154

ANALYSING THE RISKS OF DEVELOPING SECONDARY CANCERS IN PATIENTS WITH CHRONIC MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Maria Kingsley-Godwin, 4162155

EFFICACY AND SAFETY OF PEGYLATED INTERFERON IN THE TREATMENT OF JAK2V617F-POSITIVE POLYCYTHEMIA VERA WITH A DOSE DE-ESCALATION STRATEGY: A SINGLE-CENTER RETROSPECTIVE STUDY

EHA Library, Minghui Duan, 4162156

CLINICAL DETERMINANTS OF HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH JANUS KINASE INHIBITOR-EXPERIENCED MYELOFIBROSIS

EHA Library, Sean Conlon, 4162157

CHARACTERISTICS OF LOW HEMOGLOBIN POLYCYTHEMIA VERA AND RED BLOOD CELL COUNT AS A SURROGATE MARKER FOR RED CELL MASS DETERMINATION

EHA Library, Marta Garrote, 4162158

SUBSTANTIAL RESPONSES TO INTERFERON THERAPY IN PREFIBROTIC PRIMARY MYELOFIBROSIS - A RETROSPECTIVE SINGLE CENTER ANALYSIS

EHA Library, Veronika Buxhofer-Ausch, 4162159

GENETIC FEATURES OF ADVANCED AND INDOLENT FORMS OF SYSTEMIC MASTOCYTOSIS

EHA Library, Dzhariiat Shikhbabaeva, 4162160

INCIDENCE OF SECOND PRIMARY MALIGNANCIES IN CHRONIC MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Timea Gurbity Palfi, 4162161

EXTRAMEDULLARY DISEASE MODULATES BCMA CAR-T EFFICACY AND SAFETY IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: A META-ANALYSIS

EHA Library, Yan-ling Li, 4162162

LUSPATERCEPT FOR THE TREATMENT OF REFRACTORY ANEMIA IN MYELOFIBROSIS PATIENTS DURING RUXOLITINIB THERAPY

EHA Library, Na Xu, 4162163

PATIENT PERSPECTIVES ON DISEASE BURDEN AND MANAGEMENT OF HYPEREOSINOPHILIC SYNDROME IN EUROPE AND THE US: EVIDENCE FROM A REAL-WORLD SURVEY IN CLINICAL PRACTICE

EHA Library, Juliana Schwaab, 4162164

CLINICAL FEATURES AND NEXT-GENERATION SEQUENCING LANDSCAPE OF POLYCYTHEMIA VERA AND IDIOPATHIC ERYTHROCYTOSIS: A CHINESE MONOCENTRIC RETROSPECTIVE STUDY

EHA Library, Jian Huang, 4162165

HYPERCOAGULABILITY ASSESSED BY ROTATIONAL THROMBOELASTOMETRY (ROTEM) IN PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Ingrid Lundahl, 4162168

VALIDITY OF THE DANISH NATIONAL CHRONIC MYELOID NEOPLASIA REGISTRY

EHA Library, Dustin Andersen Patel, 4162169

CLINICAL AND GENETIC FEATURES OF PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA IN TAIWAN: A COMPARISON BETWEEN TWO AGE GROUPS

EHA Library, Hunglin Liu, 4162170

STEM CELL BOOST FOR POOR ENGRAFTMENT AFTER ALLOGENEIC HSCT IN PRIMARY AND SECONDARY MYELOFIBROSIS: OUTCOMES AND ANALYSIS

EHA Library, Maria Leon-Camarena, 4162171

REAL-WORLD EVIDENCE ON CLINICAL OUTCOMES AND SAFETY OF ROPEGINTERFERON ALFA-2B IN PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS: A RETROSPECTIVE COHORT STUDY

EHA Library, Tsung-Han Li, 4162173

CIRCULATING MYELOBLASTS AS BIOMARKERS OF DISEASE ACTIVITY IN MYELOFIBROSIS

EHA Library, Laszlo Pinczes, 4162174

PROGNOSTIC IMPLICATIONS OF THE SYSTEMIC INFLAMMATORY RESPONSE INDEX (SIRI) IN POLYCYTHEMIA VERA

EHA Library, Ivan Krecak, 4162175

EXTREME THROMBOCYTOSIS IN PATIENTS WITH OVERT MYELOFIBROSIS, CLINICAL CORRELATIONS AND ASSOCIATED RISKS

EHA Library, Marko Lucijanic, 4162176

HIGH-INITIAL DOSE AND ACCELERATED TITRATION REGIMEN OF ROPEGINTERFERON ALFA-2B IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA

EHA Library, Ming-Yu Lien, 4162177

APPLICATION OF TRIPLE A MODEL FOR RISK STRATIFICATION OF ESSENTIAL THROMBOCYTHAEMIA AND POLYCYTHAEMIA VERA IN UK COHORT

EHA Library, Priya Sriskandarajah, 4162178

RDW AND PDW - A NEW PREDICTIVE MODEL FOR THROMBOTIC EVENTS IN POLYCYTHEMIA VERA

EHA Library, Mara Caterina Bălan, 4162179

THE CLINICAL DIAGNOSTIC VALUE OF NEUTROPHIL-TO-LYMPHOCYTE RATIO IN PATIENTS WITH ERYTHROCYTOSIS

EHA Library, Jong-Ho Won, 4162180

PHASE 2/3 HARBOR STUDY OF ELENESTINIB IN ISM: A TRIAL-IN-PROGRESS UPDATE OF NOVEL ENDPOINTS AND BIOMARKERS AIMED AT EVALUATING DISEASE MODIFICATION

EHA Library, Ivan Alvarez-Twose, 4162181

OPEN-LABEL PHASE II CLINICAL TRIAL OF METHOTREXATE IN MYELOPROLIFERATIVE NEOPLASMS (TREATMORE TRIAL)

EHA Library, Megan Metzger, 4162182

IDENTIFICATION OF SURROGATE VARIABLES FOR PREDICTING SURVIVAL IN PATIENTS WITH MYELOFIBROSIS TREATED WITH RUXOLITINIB

EHA Library, Miguel Navarro Sánchez, 4162183

EXPLORATION OF THE MODEL FOR IMPROVING THE DIAGNOSIS AND TREATMENT LEVEL OF MYELOPROLIFERATIVE NEOPLASMS (MPN) IN CHINA: CONSTRUCTION AND ACHIEVEMENTS

EHA Library, Bing Li, 4162184

USE OF RUXOLITINIB AS SECOND-LINE TREATMENT IN PATIENTS WITH POLYCYTHAEMIA VERA: A MULTICENTRE STUDY.

EHA Library, Laura Curras Sanchez, 4162185

PLATELET COUNT OVER TIME IS NOT ASSOCIATED WITH INCIDENCE OF THROMBOSIS IN ASIAN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA

EHA Library, Yoshimasa Kamoda, 4162186

EVALUATING INTERVENTIONAL TRIALS IN MYELOFIBROSIS-ASSOCIATED ANEMIA: A SYSTEMATIC LITERATURE REVIEW OF BASELINE ANEMIA STATUS AND TRANSFUSION INDEPENDENCE OUTCOMES

EHA Library, Haifa Kathrin Al-Ali, 4162187

ANALYSIS OF THROMBOSIS EVENTS AND OUTCOMES BETWEEN JAK2 CHIP AND MPN PATIENTS: UK-BASED EXPERIENCE

EHA Library, Connor MacMillan, 4162188

TRIAL-IN-PROGRESS: A PHASE 2 STUDY OF RUXOLITINIB IN LOW-RISK ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA PATIENTS WITH HIGH SYMPTOM BURDEN

EHA Library, Joan How, 4162189

IMPACT OF DNMT3A MUTATION ON TREATMENT RESPONSE TO ROPEGINTERFERON ALPHA-2B IN PATIENTS WITH POLYCYTHEMIA VERA AND ESSENTIAL THROMBOCYTHEMIA

EHA Library, Tsewang Tashi, 4162190

PRIMARY MYELOFIBROSIS AND THROMBOTIC RISK: LOWER-RISK IPSS VS HIGHER-RISK IPSS

EHA Library, Veronica Vecchio, 4162191

SINGLE-CENTER DIAGNOSTIC FINDINGS OF SYSTEMIC MASTOCYTOSIS

EHA Library, Zarema Abdulkhalikova, 4162193

ASSOCIATION BETWEEN CHEMOTHERAPY FOR NONMETASTATIC BREAST CANCER AND RISK OF SECONDARY HEMATOLOGIC MALIGNANCIES

EHA Library, WenJing Lang, 4162194

A MULTICENTER, OPEN-LABEL PHASE 1 STUDY OF INCB160058, A FIRST-IN-CLASS JAK2 V617F MUTANT-SPECIFIC INHIBITOR, IN PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS (MPN)

EHA Library, Jason Gotlib, 4162195

SUCCESS OF INTERACTIVE CASE-BASED ONLINE EDUCATION TO ENHANCE HEMATOLOGIST/ONCOLOGISTS' MYELOFIBROSIS MANAGEMENT SKILLS

EHA Library, Sarah Elizabeth Bomba, 4162196

THE EFFECT OF THE DIFFERENT THERAPY ON FUNCTIONAL ACTIVITY OF PLASMA MICROPARTICLES IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA

EHA Library, Olga Golovina, 4162197

DECODING MYELOFIBROSIS: THE ROLE OF CYTOGENETICS IN DIAGNOSIS AND PROGNOSIS

EHA Library, Christoph Varelas, 4162198

THE USE OF ACE INHIBITORS DOES NOT HAVE AN IMPACT ON DISEASE SYMPTOMS IN PATIENTS WITH CHRONIC MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Hrvoje Holik, 4162199

JAK2 V617F/C618R MUTATION - A CHALLENGE IN DIAGNOSIS OF POLYCYTHEMIA VERA

EHA Library, Pedro Pinho Moura, 4162200

EVALUATION OF THE REVISED IPSET SCORE IN PREDICTING THROMBOTIC RISK AND GUIDING MANAGEMENT IN ESSENTIAL THROMBOCYTHEMIA

EHA Library, Ines Ben Rekaya, 4162201

MORE THAN 15 YEARS OF MASTOCYTOSIS EXPERIENCE IN A SINGLE CENTER ACCORDING TO CURRENT GUIDELINES

EHA Library, Merve Aydoğan, 4162202

CURRENT STATUS OF DIAGNOSIS AND TREATMENT FOR MYELOPROLIFERATIVE NEOPLASMS IN CHINA AND OBSERVATIONS ON CLINICIANS' PRACTICE PATTERNS

EHA Library, Bing Li, 4162203

THE EFFECT OF ALTITUDE ON POLYCYTHEMIA VERA: IS IT NECESSARY TO CHANGE LIMITS? SHORT TITLE: THE EFFECT OF ALTITUDE ON POLYCYTHEMIA

EHA Library, Edibe Sevde EKER, 4162204

REAL LIFE DATA OF YOUNG PRIMARY MYELOFIBROSIS PATIENTS IN AZERBAIJAN

EHA Library, Elmir Guluyev, 4162205

CENTRAL RETINAL VEIN OCCLUSION AS THE ONSET OF CMPN

EHA Library, Lidiya Egoryan, 4162206

POLYCYTHEMIA VERA: EPIDEMIOLOGICAL, DIAGNOSTIC, AND THERAPEUTIC INSIGHTS FROM A 16-YEAR STUDY

EHA Library, Aya Zaouali Dridi, 4162207

PRIMARY MYELOFIBROSIS: A SINGLE CENTER EXPERIENCE IN TUNISIA

EHA Library, Imen Ben Amor, 4162208

CLINICAL AND MOLECULAR CHARACTERISTICS OF ESSENTIAL THROMBOCYTHEMIA IN A MEXICAN COHORT

EHA Library, Liliana Regalado, 4162209

OUTCOMES OF MYELOPROLIFERATIVE NEOPLASMS:AN EXPERIENCE FROM A TERTIARY CENTER IN SAUDI ARABIA

EHA Library, Mousa Alhaddad, 4162210

RESULTS OF TARGET THERAPY IN PATIENTS WITH POLYCYTEMIA VERA

EHA Library, Maria Pankrashkina, 4162211

NEUTROPHIL-LYMPHOCYTE RATIO IN POLYCYTHAEMIA VERA: INSIGHTS FROM A SINGLE-CENTRE STUDY

EHA Library, Harberth Fernandez - Leyva, 4162212

IBRUTINIB FOR RELAPSED REFRACTORY CLASSIC HODGKIN LYMPHOMA: RESULTS FROM AN INVESTIGATOR-INITIATED PHASE II TRIAL

EHA Library, Dipenkumar Modi, 4162213

THE COMBINATION OF NIVOLUMAB - IFOSFAMIDE - CARBOPLATIN - ETOPOSIDE (NICE) AS SALVAGE AND MOBILIZING REGIMEN IN PATIENTS WITH RELAPSED/REFRACTORY HODGKIN LYMPHOMA

EHA Library, Athanasios Liaskas, 4162214

CD163 AS A PROGNOSTIC FACTOR IN NODULAR SCLEROSIS CLASSICAL HODGKIN LYMPHOMA AND ITS POTENTIAL CLINICAL APPLICATION

EHA Library, Maksim Minaev, 4162215

THE TREATMENT EVOLUTION OF CLASSIC HODGKIN LYMPHOMA OVER TWO DECADES IN CHINA: REAL-WORLD EXPERIENCES OF AN ACADEMIC CENTER

EHA Library, Huiying Zhu, 4162216

NUTRITIONAL STATUS AND PROGNOSIS IN HODGKIN LYMPHOMA: THE IMPACT OF THE CONUT SCORE

EHA Library, Didem KOCA, 4162217

HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM CELL TRANSPLANTATION IN HODGKIN LYMPHOMA: A MULTICENTER REAL-WORLD ANALYSIS FROM TURKEY

EHA Library, Merve Ecem Erdoğan Yön, 4162218

EFFICACY OF NIVOLUMAB PLUS AVD IN PATIENTS WITH CLASSICAL HODGKIN'S LYMPHOMA (HL): A SINGLE-CENTER EXPERIENCE (PILOT STUDY)

EHA Library, Evgenii Kunevich, 4162219

HODGKIN'S LYMPHOMA: INFILTRATION OF THE CENTRAL NERVOUS SYSTEM.

EHA Library, Lucy Gonzalez, 4162220

NOVEL COMBINATION REGIMEN BRENTUXIMAB VEDOTIN-BEGE ACHIEVES REMARKABLE EFFICACY IN PATIENTS WITH RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA

EHA Library, Xi Chen, 4162221

EMPEGFILGRASTIM SUPPORT FOR FULL-DOSE THERAPY OF 6-EACODD-14 PROGRAM FOR ADVANCED STAGES HODGKIN'S LYMPHOMA PATIENTS.

EHA Library, Vladislav Sarzhevskij, 4162222

CRP-ALBUMIN RATIO FOR PREDICTION OF INTERIM COMPLETE REMISSION AND PROGRESSION-FREE SURVIVAL IN HODGKIN LYMPHOMA

EHA Library, Tugcan Alp Kirkizlar, 4162223

EFFICACY AND SAFETY OF NIVOLUMAB IN COMBINATION WITH AVD IN PATIENTS WITH NEWLY DIAGNOSED CLASSICAL HODGKIN LYMPHOMA: A PROSPECTIVE SINGLE-CENTER CLINICAL TRIAL

EHA Library, Diana Ivanova, 4162224

EPIDEMIOLOGICAL CHARACTERISTICS OF HODGKIN'S LYMPHOMA IN BRAZIL: INCIDENCE AND GEOGRAPHIC DISTRIBUTION.

EHA Library, Gerson de Paula, 4162225

PERSONALIZED NIVOLUMAB-BASED DE-ESCALATED STRATEGY AS FRONTLINE THERAPY FOR HIGH-RISK PATIENTS WITH CLASSICAL HODGKIN LYMPHOMA

EHA Library, Anna Kravtsova, 4162226

IMPACT OF OMISSION OF BLEOMYCIN ON LONG TERM SURVIVAL IN ADVANCED STAGE HODGKIN LYMPHOMA IMPACT OF OMISSION OF BLEOMYCIN ON LONG TERM SURVIVAL IN ADVANCED STAGE HODGKIN LYMPHOMA

EHA Library, Mohammad Al-Rwashdeh, 4162227

THE RELATIONSHIP BETWEEN PROGNOSTIC NUTRITIONAL INDEX AT THE TIME OF DIAGNOSIS AND PROGNOSIS IN PATIENTS WITH HODGKIN'S LYMPHOMA

EHA Library, Serife Solmaz, 4162228

CLASSICAL HODGKIN LYMPHOMA IN MOROCCO : A RETROSPECTIVE STUDY HIGHLIGHTING MANAGEMENT STRATEGIES AND SOCIO-ECONOMIC CHALLENGES

EHA Library, Yossra AGHOUTANE, 4162229

SMARTCYTOFLOW 2.0: INTEGRATING GENERATIVE AI FOR EXPLAINABLE AND ACTIONABLE FLOW CYTOMETRY ANALYSIS IN NON-HODGKIN LYMPHOMA DIAGNOSIS

EHA Library, Adrian Mosquera Orgeira, 4162230

PRIMAVERA: A PHASE I/II STUDY TO EVALUATE SAFETY AND EFFICACY OF AZD3470, A PROTEIN ARGININE METHYLTRANSFERASE 5 (PRMT5) INHIBITOR, IN PARTICIPANTS WITH RELAPSED/REFRACTORY HEMATOLOGIC MALIGNANCIES

EHA Library, Enrico Derenzini, 4162231

REAL-WORLD USE OF BRENTUXIMAB VEDOTIN IN ADULT PATIENTS WITH CLASSICAL HODGKIN LYMPHOMA: A RETROSPECTIVE ANALYSIS FROM A COLOMBIAN HEALTHCARE REGISTRY (2016-2023)

EHA Library, Leonardo Enciso-Olivera, 4162232

BRENTUXIMAB VEDOTIN AND CHECK POINT INHIBITORS COMBINATION THERAPY IN HEAVELY PRE-TREATED RELAPSED REFRACTORY HODGKIN'S LYMPHOMA: A SINGLE CENTRE RETROSPECTIVE ANALYSIS

EHA Library, Fatima Lamraoui, 4162233

EXPLORING THE IMMUNOGENETIC LINK BETWEEN YOUNG-ONSET HODGKIN LYMPHOMA AND MULTIPLE SCLEROSIS: A TWO-CASE REPORT ON DISEASE CO-OCCURRENCE

EHA Library, Elena Pîrvu, 4162234

BV-AVD 1ST LINE TREATMENT RETROSPECTIVE ANALYSIS, KUWAIT CANCER CENTER EXPERIENCE.

EHA Library, Rasha Abd El-Tawab Hamed, 4162235

EVALUATION OF FIRST-LINE TREATMENT WITH ABVD REGIMEN IN PATIENTS WITH ADVANCED STAGE HODGKIN LYMPHOMA (STAGE III-IV)

EHA Library, Karen Torres, 4162236

PEMBROLIZUMAB AS A THERAPEUTIC STRATEGY FOR HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS SECONDARY TO HODGKIN'S LYMPHOMA

EHA Library, Barbara Jezeršek Novaković, 4162237

REAL WORLD OUTCOMES OF PET-ADAPTED TREATMENT OF CLASSIC HODGKIN'S LYMPHOMA: A SINGLE TERTIARY CARE CENTER STUDY

EHA Library, IMRAN IFTIKHAR, 4162238

BRENTUXIMAB VEDOTIN USED IN RELAPSED/REFRACTORY HODGKIN LYMPHOMA: AN EXPERIENCE FROM NORTH MACEDONIA

EHA Library, Slobodanka Trpkovska Terzieva, 4162239

HODGKIN'S LYMPHOMA IN A TUNISIAN HEMATOLOGY CENTER: CLINICAL AND THERAPEUTIC OUTCOMES UNDER A STANDARDIZED PROTOCOL

EHA Library, Kmar Mrad, 4162240

A CLINICAL CHALLENGE: PEMBROLIZUMAB-INDUCED CARDIOTOXICITY IN A TEENAGER WITH HODGKIN LYMPHOMA - CASE REPORT AND LITERATURE REVIEW

EHA Library, ichrak hajaj, 4162241

FAILURE OF FRONTLINE TREATMENT IN HODGKIN LYMPHOMA AND THE OUTCOMES OF SALVAGE THERAPY - 20 YEARS EXPERIENCE IN A SINGLE INSTITUTION

EHA Library, Tran-Der Tan, 4162242

REAL WORLD OUTCOMES OF PET-ADAPTED TREATMENT OF CLASSIC HODGKIN'S LYMPHOMA: A SINGLE TERTIARY CARE CENTRE STUDY

EHA Library, IMRAN IFTIKHAR, 4162243

LYMPHADENOPATHY IN SYSTEMIC LUPUS ERYTHEMATOSUS: CHARACTERISTICS AND DEVELOPMENT OF A PREDICTIVE RISK MODEL.

EHA Library, Blanca Sanchez-Gonzalez, 4162244

PET-ADAPTED APPROACHES TO PRIMARY THERAPY FOR CLASSICAL HODGKIN LYMPHOMA IN ARMENIA, A MIDDLE-INCOME COUNTRY.

EHA Library, Davit Melkonyan, 4162245

EPIDEMIOLOGICAL TRENDS AND PATTERNS OF HODGKIN LYMPHOMA AMONG SAUDI NATIONALS: A 10-YEAR RETROSPECTIVE ANALYSIS (2011-2020)

EHA Library, Abdulrahman Algarni, 4162246

AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR RELAPSED OR REFRACTORY HODGKIN'S LYMPHOMA IN PEDIATRIC PATIENTS: A SINGLE-CENTER STUDY.

EHA Library, Roua Hsasna, 4162247

REFRACTORY AND/OR RELAPSED HODGKIN'S LYMPHOMA: A MONOCENTRIC EXPERIENCE OF THE HEMATOLOGY DEPARTMENT OF MONASTIR.

EHA Library, oumeyma touati, 4162248

PREVALENCE, RESPONSE TO TREATMENT AND OUTCOME OF LIMITED-STAGE FOLLICULAR LYMPHOMA: A SINGLE-CENTER RETROSPECTIVE STUDY.

EHA Library, Marco Carraro, 4162249

BRIDGING GAPS IN MANTLE CELL LYMPHOMA (MCL) MANAGEMENT: A GLOBAL COMPARISON OF BTK INHIBITOR USAGE AMONG EXPERTS AND HEALTHCARE PROFESSIONALS

EHA Library, Ryan Topping, 4162250

STUDY RESULTS ON TP53 GENE ALTERATIONS IN PATIENTS WITH CUTANEOUS T-CELL LYMPHOMAS INTRODUCTION

EHA Library, Liliya Gorenkova, 4162251